pre-IPO PHARMA

tmunity PRESS RELEASE ARCHIVE

Dec 20, 2022

Kite to Acquire Tmunity Therapeutics to Pursue Next Generation CAR T-Cell Therapy Advancements in Cancer


Feb 9, 2021

Tmunity Therapeutics Announces Expansion of T Cell Engineered Therapy Collaboration


Jan 25, 2021

Tmunity Announces Appointment of Jeffrey Leiden M.D., Ph.D. as Chairman of the Board of Directors


Jan 5, 2021

Tmunity to Present at the 39th Annual J.P. Morgan Healthcare Conference


Dec 9, 2020

Tmunity to Present at the 2020 RBC Capital Markets Healthcare Private Company Conference



Nov 5, 2020

Tmunity to Present at Upcoming Investor Conferences


Sep 29, 2020

Tmunity to Present at Upcoming Investor Conferences


Sep 8, 2020

Tmunity Announces Additional Senior Leadership Appointments


Feb 19, 2020

Tmunity to Present at Upcoming Investor Conferences


Feb 19, 2020

Tmunity to Present at Upcoming Investor Conferences



Jan 15, 2020

Tmunity Announces First Patient Dosed in Phase 1 Clinical Trial with CART-TnMUC1


Jan 15, 2020

Tmunity Announces First Patient Dosed in Phase 1 Clinical Trial with CART-TnMUC1


Jan 9, 2020

Tmunity to Present at the 38th Annual J.P. Morgan Healthcare Conference


Jan 9, 2020

Tmunity to Present at the 38th Annual J.P. Morgan Healthcare Conference


Nov 4, 2019

Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients



Nov 4, 2019

Tmunity and Oncora Medical Partner to Advance the Use of Real-World Data to Accelerate the Availability of CAR-T Therapies for Cancer Patients


Oct 31, 2019

Tmunity Raises $75 Million in Series B Financing to Advance Next-Generation T-Cell Therapies


Oct 31, 2019

Tmunity Raises $75 Million in Series B Financing to Advance Next-Generation T-Cell Therapies


Oct 1, 2019

Tmunity Announces Exclusive License and Research Collaboration with Children’s Hospital of Philadelphia to Advance GPC2 CAR-T Cell Therapy for Neuroblastoma


Oct 1, 2019

Tmunity Announces Exclusive License and Research Collaboration with Children’s Hospital of Philadelphia to Advance GPC2 CAR-T Cell Therapy for Neuroblastoma



Sep 27, 2019

Tmunity Announces Presentation at the Cantor Fitzgerald 2019 Global Healthcare Conference


Sep 27, 2019

Tmunity Announces Presentation at the Cantor Fitzgerald 2019 Global Healthcare Conference


Aug 23, 2019

Tmunity Announces Participation at Upcoming Investor Conferences


Aug 23, 2019

Tmunity Announces Participation at Upcoming Investor Conferences


Jul 9, 2019

Be The Match BioTherapies® and Tmunity Announce Collaboration to Support Clinical Trials of Next-Generation Immunotherapies



Jul 9, 2019

Be The Match BioTherapies and Tmunity Announce Collaboration to Support Clinical Trials of Next-Generation Immunotherapies


May 23, 2019

Tmunity Announces June 2019 Investor Conference Schedule


May 1, 2019

Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers


May 1, 2019

Tmunity and UC San Francisco Announce Exclusive License and Research Collaboration to Advance TCR T Cell Therapies for Pediatric Cancers


Mar 1, 2019

Tmunity Announces Participation at Four Upcoming Investor Conferences



Mar 1, 2019

Tmunity Announces Participation at Four Upcoming Investor Conferences


Feb 14, 2019

Tmunity Appoints Patrick Gray and Garry Nicholson to its Board of Directors as Independent Directors


Feb 14, 2019

Tmunity Appoints Patrick Gray and Garry Nicholson to its Board of Directors as Independent Directors


Dec 21, 2018

Tmunity to Present at the 37th Annual J.P. Morgan Healthcare Conference


Dec 21, 2018

Tmunity to Present at the 37th Annual J.P. Morgan Healthcare Conference



Oct 2, 2018

FierceBiotech Names Tmunity as One of Its “Fierce 15” Biotech Companies of 2018


Oct 2, 2018

FierceBiotech Names Tmunity as One of Its “Fierce 15” Biotech Companies of 2018


Sep 19, 2018

Abzena Announces a Research and Licence Agreement with Tmunity Therapeutics, a T Cell Engineering Company


Sep 19, 2018

Abzena Announces a Research and Licence Agreement with Tmunity Therapeutics, a T Cell Engineering Company


Sep 18, 2018

Tmunity Names Moji James as General Counsel and Executive Vice President



Sep 18, 2018

Tmunity Names Moji James as General Counsel and Executive Vice President


Sep 4, 2018

Tmunity Names Graeme Bell as Chief Financial Officer and Executive Vice President


Sep 4, 2018

Tmunity Names Graeme Bell as Chief Financial Officer and Executive Vice President


Jul 10, 2018

Tmunity Appoints Christina Coughlin, MD, PhD, as Chief Medical Officer and Executive Vice President


Jul 10, 2018

Tmunity Appoints Christina Coughlin, MD, PhD, as Chief Medical Officer and Executive Vice President



Apr 19, 2018

Tmunity Raises Additional $35 Million in Series A Financing, Bringing Series A Total to $135 Million to Advance Next-Generation T Cell Therapies


Apr 19, 2018

Tmunity Raises Additional $35 Million in Series A Financing, Bringing Series A Total to $135 Million to Advance Next-Generation T Cell Therapies


Apr 3, 2018

Tmunity Appoints Jason Krentz as Chief Technology Officer and Head of Technical Operations


Apr 3, 2018

Tmunity Appoints Jason Krentz as Chief Technology Officer and Head of Technical Operations


Jan 23, 2018

Tmunity Therapeutics Raises $100 Million in Series A Financing to Advance Portfolio of Next-Generation T cell Immunotherapies to Transform the Treatment of Cancer



Jan 23, 2018

Be The Match BioTherapies Invests in Tmunity Therapeutics to Support Advancement of Next-Generation T cell Immunotherapies


Jan 23, 2018

Tmunity Therapeutics Raises $100 Million in Series A Financing to Advance Portfolio of Next-Generation T cell Immunotherapies to Transform the Treatment of Cancer


Jan 23, 2018

Be The Match BioTherapies Invests in Tmunity Therapeutics to Support Advancement of Next-Generation T cell Immunotherapies


May 9, 2017

Tmunity Therapeutics Names Michael Christiano Executive Vice President and Chief Business Officer


May 9, 2017

Tmunity Therapeutics Names Michael Christiano Executive Vice President and Chief Business Officer



Dec 7, 2016

Tmunity Therapeutics Names Usman “Oz” Azam Chief Executive Officer


Dec 7, 2016

Tmunity Therapeutics Names Usman “Oz” Azam Chief Executive Officer


Dec 7, 2016

Tmunity Therapeutics Names Usman “Oz” Azam Chief Executive Officer


Jan 12, 2016

Tmunity Therapeutics, Inc. to Advance IND-Enabling Activities for Personalized Next-Generation Engineered T Cell Therapies with $10 Million Financing


Google Analytics Alternative